Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 495

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 495
---
 |
| Lauren Chung                      |     |  48 |     | Director                                       |
| Peter O’Rourke                    |     |  52 |     | Lead Independent Director                      |
| Jack Stover                       |     |  71 |     | Director                                       |

A description of the business experience of Ben C. Hwang, Ph.D., is provided above under the heading “Management of Profusa — Executive Officers.” A description of the business experience of Fred Knechtel, Lauren Chung, Peter O’Rourke, and Jack Stover, is provided above under the heading “Information about Northview — Directors and Executive Officers.” Rajesh Asarpota— Mr. Asarpota is currently the chief financial officer at Augmedics, a company that has pioneered cutting -edgeaugmented reality technologies to improve surgical outcomes for spine surgery. Prior to Augmedics, from September 2020 to October 2021, he served at ApiJect as executive vice president, chief financial officer and head of technology. ApiJect is a medical technology company that seeks to revolutionize how medicines and vaccines are filled, finished and delivered. Prior to ApiJect, from August 2017 to September 2020, Asarpota served as executive vice president and chief financial officer with NuVasive, a global public company and leader in minimally invasive, procedurally integrated spine solutions. Prior to NuVasive, he spent two years in the private equity space at Imaging Advantage and Cole Parmer as executive vice president and chief financial officer. Imaging Advantage was acquired by Envision in 2015. In 2014, he served as the executive vice president and chief financial officer for Questcor Pharmaceuticals which was acquired by Mallinckrodt in a $5.6B transaction. Mr.Asarpota also spent a decade at Life Technologies, a global life sciences company where he was responsible for helping scale the organization, driving growth through organic and M&A channels. During his tenure, the company revenue grew from approximately $1B to more than $4B in 2014, leading to the company’s sale to Thermo Fisher for $13.6 billion that year. Prior to Life Technologies, Mr. Asarpota spent 11 years at GE in several finance leadership roles. Mr. Asarpota holds a M.B.A. from Marquette University and a Bachelor of Commerce from the University of Bombay. We believe that Mr. Asarpota is well -qualifiedto serve as a director of our company based